Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering, the second-largest exporter of ...

Venture Global liquefied natural gas (LNG) is forced to nearly halve the valuation it is seeking in its US initial public offering (IPO) after investors balked at the company’s estimated long-term ...

This edition of the Bermuda Public Companies Update summarises significant transactions involving Bermuda companies listed on the New York ...

The company has partnered with Kotak Mahindra Capital, IIFL Capital, Goldman Sachs, Jefferies, ICICI Securities, HSBC Securities, Motilal Oswal Financial Services, and Nuvama Wealth Management, to ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

Shares surged through the $40 level as the stock gained another 20%. Nano Nuclear shares are now trading 75& higher in 2025 ...

In anticipation of the share listing, the trends in the GMP for Stallion India Fluorochemicals IPO and analysts suggest a ...

CapitalNumbers Infotech IPO allotment status online check can be done through the BSE website or through the official portal ...

Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...

Financial analysis of American National Group's preferred stock ANG-D reveals concerns about dividend payments and market ...